The purpose of this study was to test the hypothesis that the long-term use of highly (>98%)
purified EPA, in addition to HMG-CoA reductase inhibitor (statin), would be more effective
than statin alone in preventing cardiovascular events in Japanese patients with
hypercholesterolemia.